CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-22 | Invesco Ltd. 10% owner | Purchase · Warrants | +2,127,659 | $0.01 | $21K | 2,127,659 |
| 2018-05-08 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +12,875 | 12,875 | ||
| 2018-05-08 | Greer Gillian Director | Grant or award · Stock option (right to buy) | +12,875 | 12,875 | ||
| 2018-05-08 | Lynch Thomas G Director | Grant or award · Stock option (right to buy) | +12,875 | 12,875 | ||
| 2018-05-08 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +12,875 | 12,875 | ||
| 2018-05-08 | Hall William Walmsley Director | Grant or award · Stock option (right to buy) | +12,875 | 12,875 | ||
| 2018-03-12 | O'Brien Anthony Stephen Director | Grant or award · Stock option (right to buy) | +24,691 | 24,691 | ||
| 2018-03-12 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2018-03-12 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +24,691 | 24,691 | ||
| 2018-03-12 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +825,000 | 825,000 | ||
| 2018-03-12 | Lynch Thomas G Director | Grant or award · Stock option (right to buy) | +24,691 | 24,691 | ||
| 2018-03-12 | Lynch Thomas G Director | Grant or award · Stock option (right to buy) | +225,000 | 225,000 | ||
| 2018-03-12 | Hall William Walmsley Director | Grant or award · Stock option (right to buy) | +24,691 | 24,691 | ||
| 2018-03-12 | Greer Gillian Director | Grant or award · Stock option (right to buy) | +24,691 | 24,691 | ||
| 2018-03-12 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +275,000 | 275,000 | ||
| 2018-03-12 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2018-03-12 | Culwell Kelly Chief Medical Officer | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | ||
| 2018-03-12 | Barrans Russell Chief Commercial Officer | Grant or award · Stock option (right to buy) | +260,000 | 260,000 | ||
| 2018-01-17 | Rutherford Colin Director | Grant or award · Stock Option (right to buy) | +770 | 770 | ||
| 2018-01-17 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock Option (right to buy) | +19,249 | 19,249 |
Page 12 of 20 · 383 trades